James H. Sabry, Executive Chairman at CYTOKINETICS INC (CYTK), sold 60,000 shares at $2.84 ($172K) on 2009-06-04, disclosed to the SEC on 2009-06-08.
Open-market sale of $172k CYTK by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.80 | 1,044 | $3K | 1.7% |
| 2 | $2.81 | 1,300 | $4K | 2.1% |
| 3 | $2.82 | 3,600 | $10K | 5.9% |
| 4 | $2.83 | 4,062 | $11K | 6.7% |
| 5 | $2.84 | 200 | $568 | 0.3% |
| 6 | $2.84 | 4,638 |
| $13K |
| 7.7% |
| 7 | $2.85 | 3,400 | $10K | 5.6% |
| 8 | $2.86 | 1,356 | $4K | 2.3% |
| 9 | $2.87 | 400 | $1K | 0.7% |
| 10 | $2.88 | 600 | $2K | 1.0% |
| 11 | $2.89 | 1,500 | $4K | 2.5% |
| 12 | $2.90 | 1,100 | $3K | 1.9% |
| 13 | $2.91 | 3,065 | $9K | 5.2% |
| 14 | $2.92 | 2,626 | $8K | 4.5% |
| 15 | $2.93 | 1,309 | $4K | 2.2% |
| 16 | $2.82 | 100 | $282 | 0.2% |
| 17 | $2.83 | 3,500 | $10K | 5.8% |
| 18 | $2.84 | 1,900 | $5K | 3.1% |
| 19 | $2.85 | 5,200 | $15K | 8.6% |
| 20 | $2.86 | 4,133 | $12K | 6.9% |
| 21 | $2.87 | 3,300 | $9K | 5.5% |
| 22 | $2.87 | 267 | $766 | 0.4% |
| 23 | $2.88 | 6,900 | $20K | 11.6% |
| 24 | $2.89 | 3,292 | $10K | 5.5% |
| 25 | $2.90 | 1,108 | $3K | 1.9% |
| 26 | $2.91 | 100 | $291 | 0.2% |
| Total | $2.86 avg | 60,000 | $172K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |